Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$161.19 - $257.96 $161,190 - $257,959
-1,000 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$165.87 - $220.95 $165,870 - $220,950
1,000 New
1,000 $200,000
Q4 2020

Feb 10, 2021

SELL
$148.08 - $206.57 $430,172 - $600,085
-2,905 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$73.84 - $93.08 $214,505 - $270,397
2,905 New
2,905 $290,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cfm Wealth Partners LLC Portfolio

Follow Cfm Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfm Wealth Partners LLC with notifications on news.